Related references
Note: Only part of the references are listed.Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation
Jens Erik Nielsen-Kudsk et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2021)
Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device Results From the PINNACLE FLX Trial
Saibal Kar et al.
CIRCULATION (2021)
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
Richard P. Whitlock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Left atrial appendage occlusion with the AmplatzerTM AmuletTM device: full results of the prospective global observational study
David Hildick-Smith et al.
EUROPEAN HEART JOURNAL (2020)
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation
Pavel Osmancik et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Left atrial appendage closure versus medical therapy in patients with atrial fibrillation: the APPLY study
Steffen Gloekler et al.
EUROINTERVENTION (2020)
Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage
Lucas V. Boersma et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2019)
Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries
David R. Holmes et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Impact of Non-vitamin K Antagonist Oral Anticoagulant Withdrawal on Stroke Outcomes
Joong Hyun Park et al.
FRONTIERS IN NEUROLOGY (2018)
5-Year Outcomes After Left Atrial Appendage Closure From the PREVAIL and PROTECT AF Trials
Vivek Y. Reddy et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Interventional left atrial appendage closure vs novel anticoagulation agents in patients with atrial fibrillation indicated for long-term anticoagulation (PRAGUE-17 study)
Pavel Osmancik et al.
AMERICAN HEART JOURNAL (2017)
Percutaneous Left Atrial Appendage Closure vs Warfarin for Atrial Fibrillation A Randomized Clinical Trial
Vivek Y. Reddy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Treatment Discontinuations With New Oral Agents for Long-term Anticoagulation: Insights From a Meta-analysis of 18 Randomized Trials Including 101,801 Patients
Saurav Chatterjee et al.
MAYO CLINIC PROCEEDINGS (2014)
Outcomes of Discontinuing Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation Analysis From the ROCKET AF Trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)
Manesh R. Patel et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Apixaban in Patients with Atrial Fibrillation
Stuart J. Connolly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial
David R. Holmes et al.
LANCET (2009)
Prevention of thromboembolism in atrial fibrillation - A meta-analysis of trials of anticoagulants and antiplatelet drugs
JB Segal et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2000)
Share Paper
